Nickel-responding T cells are CD4+ CLA+ CB45RO+ and express chemokine receptors CXCR3, CCR4 and CCR10

British Journal of Dermatology

Volumn 151, Issue 1, 2004, Pages 32-41

  Moed, H ^a   Boorsma, D M ^a   Stoof, T J ^a   Von Blomberg, B M E ^a   Bruynzeel, D P ^a   Scheper, R J ^a   Gibbs, S ^a   Rustemeyer, T ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Allergic contact dermatitis; Chemokine receptor; Cytokines; Human; Nickel; T lymphocytes

Indexed keywords

ALLERGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD69 ANTIGEN; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; INTERLEUKIN 5; NICKEL;

ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CELL STIMULATION; CELL TYPE; CLINICAL ARTICLE; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, CD4; ANTIGENS, CD45; ANTIGENS, NEOPLASM; CASE-CONTROL STUDIES; DERMATITIS, ALLERGIC CONTACT; DRUG ERUPTIONS; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; MEMBRANE GLYCOPROTEINS; NICKEL; RECEPTORS, CHEMOKINE; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTE SUBSETS;

EID: 4043140734     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.05975.x     Document Type: Article

References (36)

1. Sinigaglia F, Scheidegger D, Garotta G et al. Isolation and characterization of Ni-specific T cell clones from patients with Ni-contact dermatitis. J Immunol 1985; 135: 3929-32.
2. Kapsenberg ML, Wierenga EA, Stiekema FE et al. Th1 lymphokine production profiles of nickel-specific CD4+ T lymphocyte clones from nickel contact allergic and non-allergic individuals. J Invest Dermatol 1992; 98: 59-63.
3. Cavani A, Mei D, Guerra E et al. Patients with allergic contact dermatitis to nickel and nonallergic individuals display different nickel-specific T cell responses. Evidence for the presence of effector CD8+ and regulatory CD4+ T cells. J Invest Dermatol 1998; 111: 621-8.
4. Moulon C, Wild D, Dormoy A et al. MHC-dependent and -independent activation of human nickel-specific CD8+ cytotoxic T cells from allergic donors. J Invest Dermatol 1998; 111: 360-6.
5. Lisby S, Hansen LH, Skov L et al. Nickel-induced activation of T cells in individuals with negative patch tests to nickel sulphate. Arch Dermatol Res 1999; 291: 247-52.
6. Werfel T, Hentschel M, Kapp A et al. Dichotomy of blood- and skin-derived IL-4-producing allergen-specific T cells and restricted V beta repertoire in nickel-mediated contact dermatitis. J Immunol 1997; 158: 2500-5.
7. Budinger L, Neuser N, Totzke U et al. Preferential usage of TCR-Vbeta17 by peripheral and cutaneous T cells in nickel-induced contact dermatitis. J Immunol 2001; 10: 6038-44.
8. Borg L, Christensen JM, Kristiansen J et al. Nickel-induced cytokine production from mononuclear cells in nickel-sensitive individuals and controls. Cytokine profiles in nickel-sensitive individuals with nickel allergy-related hand eczema before and after nickel challenge. Arch Dermatol Res 2000; 292: 285-91.
9. Jakobson E, Masjedi K, Ahlborg N et al. Cytokine production in nickel-sensitized individuals analysed with enzyme-linked immunospot assay: possible implication for diagnosis. Br J Dermatol 2002; 147: 442-9.
10. Picker LJ, Michie SA, Rott LS et al. A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol 1990; 136: 1053-68.
11. Duijvestijn AM, Horst E, Pals ST et al. High endothelial differentiation in human lymphoid and inflammatory tissues defined by monoclonal antibody HECA-452. Am J Pathol 1988; 130: 147-55.
12. Robert C, Kupper TS. Inflammatory skin diseases, T cells, and immune surveillance. N Engl J Med 1999; 341: 1817-28.
13. Loetscher M, Gerber B, Loetscher P et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T lymphocytes. J Exp Med 1996; 184: 963-9.
14. Albanesi C, Scarponi C, Sebastiani S et al. IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines. J Immunol 2000; 165: 1395-402.
15. Flier J, Boorsma DM, Bruynzeel DP et al. The CXCR3 activating chemokines IP-10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions. J Invest Dermatol 1999; 113: 574-8.
16. Flier J, van Boorsma DM, Beek PJ et al. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol 2001; 194: 398-405.
17. Liao F, Rabin RL, Smith CS et al. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J Immunol 1999; 162: 186-94.
18. Reiss Y, Proudfoot AE, Power CA et al. CC chemokine receptor (CCR) 4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 2001; 194: 1541-7.
19. Homey B, Alenius H, Muller A et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002; 8: 157-65.
20. Dennig D, O'Reilly RJ. IL-7 induces surface expression of B7/BB1 on pre-B cells and an associated increase in their costimulatory effects on T cell proliferation. Cell Immunol 1994; 153: 227-38.
21. Armitage RJ, Namen AE, Sassenfeld HM et al. Regulation of human T cell proliferation by IL-7. J Immunol 1990; 3: 938-41.
22. Mehrotra PT, Grant AJ, Siegel JP. Synergistic effects of IL-7 and IL-12 on human T cell activation. J Immunol 1995; 154: 5093-102.
23. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179: 1109-18.
24. Weltzien HU, Moulon C, Martin S et al. T cell immune responses to haptens. Structural models for allergic and autoimmune reactions. Toxicology 1996; 107: 141-51.
25. Bonecchi R, Bianchi G, Bordignon PP et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998; 187: 129-34.
26. Rothstein DM, Yamada A, Schlossman SF et al. Cyclic regulation of CD45 isoform expression in a long term human CD4+CD45RA+ T cell line. J Immunol 1991; 146: 1175-83.
27. Liu Z, Wong JT. Proliferative and regenerative capacities of CD4(+) T cells upon TCR stimulation. Clin Immunol 1999; 93: 16-23.
28. Suarez A, Mozo L, Gutierrez C, Generation of CD4(+) CD45RA(+) effector T cells by stimulation in the presence of cyclic adenosine 5′-monophosphate- elevating agents. J Immunol 2002; 169: 1159-67.
29. Cher DJ, Mosmann TR. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol 1987; 138: 3688-94.
30. Cavani A, Albanesi C. Traidl C et al. Effector and regulatory T cells in allergic contact dermatitis. Trends Immunol 2001; 22: 118-20.
31. Sallusto F, Lanzavecchia A, Mackay CR. Chemokines and chemokine receptors in T cell priming and Th1/Th2-mediated responses. Immunol Today 1998; 19: 568-74.
32. Sebastiani S, Albanesi C, Nasorri F et al. Nickel-specific CD4(+) and CD8(+) T cells display distinct migratory responses to chemokines produced during allergic contact dermatitis. J Invest Dermatol 2002; 118: 1052-8.
33. Kunkel EJ, Boisvert J, Murphy K et al. Expression of the chemokine receptors CCR4. CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am J Pathol 2002; 160: 347-55.
34. Campbell JJ, Haraldsen G, Pan J et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999; 400: 776-80.
35. Hudak S, Hagen M, Liu Y et al. Immune surveillance and effector functions of CCR10(+) skin homing T cells. J Immunol 2002; 169: 1189-96.
36. Homey B, Dieu-Nosjean MC, Wiesenborn A et al. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 2000; 164: 6621-32.